<DOC>
	<DOCNO>NCT00103922</DOCNO>
	<brief_summary>This study design determine investigational drug effective safe individual COPD ( chronic pulmonary disease )</brief_summary>
	<brief_title>Study In Subjects With COPD ( Chronic Obstructive Pulmonary Disease )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Cilomilast</mesh_term>
	<criteria>Inclusion criterion : Diagnosis COPD history cigarette smoking . Exclusion criterion : Significant heart lung disease associate COPD . Significant stomach intestinal disease .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>smoker cough</keyword>
</DOC>